Patents Assigned to Cincera Therapeutics Pty Ltd
  • INHIBITOR COMPOUNDS
    Publication number: 20220274970
    Abstract: The disclosure relates to heterocyclic compounds and methods for their preparation. The disclosure provides compounds that may have beneficial therapeutic activity in the treatment of a disease or condition mediated by excessive or otherwise undesirable Des1 and/or fibrotic activity.
    Type: Application
    Filed: July 24, 2020
    Publication date: September 1, 2022
    Applicant: Cincera Therapeutics Pty Ltd
    Inventors: Bernard Luke FLYNN, Giang LE, Shuxin YANG